- Home
- ATEC vs VCYT Comparison
ATEC vs VCYT Comparison
Compare ATEC & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATEC
- VCYT
- Stock Information
- Founded
- ATEC 1990
- VCYT 2006
- Country
- ATEC United States
- VCYT United States
- Employees
- ATEC N/A
- VCYT N/A
- Industry
- ATEC Medical/Dental Instruments
- VCYT Medical Specialities
- Sector
- ATEC Health Care
- VCYT Health Care
- Exchange
- ATEC Nasdaq
- VCYT Nasdaq
- Market Cap
- ATEC 2.3B
- VCYT 2.4B
- IPO Year
- ATEC 2006
- VCYT 2013
- Fundamental
- Price
- ATEC $16.14
- VCYT $31.00
- Analyst Decision
- ATEC Strong Buy
- VCYT Buy
- Analyst Count
- ATEC 8
- VCYT 9
- Target Price
- ATEC $17.38
- VCYT $39.89
- AVG Volume (30 Days)
- ATEC 3.2M
- VCYT 2.3M
- Earning Date
- ATEC 07-31-2025
- VCYT 08-06-2025
- Dividend Yield
- ATEC N/A
- VCYT N/A
- EPS Growth
- ATEC N/A
- VCYT N/A
- EPS
- ATEC N/A
- VCYT 0.34
- Revenue
- ATEC $682,236,000.00
- VCYT $479,129,000.00
- Revenue This Year
- ATEC $23.76
- VCYT $12.57
- Revenue Next Year
- ATEC $18.26
- VCYT $10.23
- P/E Ratio
- ATEC N/A
- VCYT $92.35
- Revenue Growth
- ATEC 26.27
- VCYT 19.91
- 52 Week Low
- ATEC $4.88
- VCYT $22.61
- 52 Week High
- ATEC $16.47
- VCYT $47.32
- Technical
- Relative Strength Index (RSI)
- ATEC 77.41
- VCYT 68.04
- Support Level
- ATEC $15.40
- VCYT $26.61
- Resistance Level
- ATEC $15.98
- VCYT $30.63
- Average True Range (ATR)
- ATEC 0.46
- VCYT 1.18
- MACD
- ATEC 0.04
- VCYT 0.36
- Stochastic Oscillator
- ATEC 83.16
- VCYT 96.01
About ATEC Alphatec Holdings Inc.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.